UPDATE: Sio Gene Therapies to Present New Data at the
Oral presentation to discuss new data updates from the high- and low-dose cohorts from the ongoing Phase 1/2 trial of AXO-AAV-GM1 for the treatment of GM1...
Source: globenewswire.com
Stay updated with breaking news from Sandhoff Diseases. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Oral presentation to discuss new data updates from the high- and low-dose cohorts from the ongoing Phase 1/2 trial of AXO-AAV-GM1 for the treatment of GM1...